Transbarrier targeting in the intestine: nanomedical options in oncology

Int J Clin Pharmacol Ther. 2012 Jan;50(1):55-64. doi: 10.5414/cpp50055.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Antineoplastic Agents / administration & dosage
  • Antineoplastic Agents / pharmacokinetics
  • Antineoplastic Agents / therapeutic use*
  • Dose-Response Relationship, Drug
  • Drug Delivery Systems*
  • Drug Design
  • Humans
  • Intestinal Mucosa / metabolism
  • Nanoparticles
  • Neoplasms / drug therapy*
  • Neoplasms / pathology
  • Tissue Distribution

Substances

  • Antineoplastic Agents